High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
…, M Ubeira-Iglesias, M Montero-Baladía… - Journal of …, 2020 - Elsevier
Objective Severely ill COVID-19 patients may end in acute respiratory distress syndrome (ARDS)
and multi-organ failure. Some of them develop a systemic hyperinflammatory state …
and multi-organ failure. Some of them develop a systemic hyperinflammatory state …
[HTML][HTML] Corticosteroid pulses for hospitalized patients with COVID-19: effects on mortality
…, JÁ Martín-Oterino, M Montero-Baladia… - Mediators of …, 2021 - ncbi.nlm.nih.gov
Objectives To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized
patients with severe COVID-19. Methods We designed a multicenter retrospective cohort …
patients with severe COVID-19. Methods We designed a multicenter retrospective cohort …
[HTML][HTML] Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients
BM Luis, MB Miguel, DL Pedro, IP David, A Itziar… - Journal of translational …, 2021 - Elsevier
Introduction A growing evidence suggests that immune dysregulation and thrombotic
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
…, L Buzón-Martín, M Montero-Baladia… - Chest, 2021 - journal.chestnet.org
To the Editor: We have read with interest the article published in CHEST (January 2021) by
Patel et al 1 in which the authors present a single case of cytokine storm due to coronavirus …
Patel et al 1 in which the authors present a single case of cytokine storm due to coronavirus …
[PDF][PDF] Research Article Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality
…, JÁ Martín-Oterino, M Montero-Baladia… - 2021 - scienceopen.com
Objectives. To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized
patients with severe COVID-19. Methods. We designed a multicenter retrospective cohort …
patients with severe COVID-19. Methods. We designed a multicenter retrospective cohort …
Corticosteroid pulses for hospitalized patients with COVID-19. Effects on mortality and in-hospital stay.
…, JA Martin-Oterino, M Montero-Baladia… - 2020 - pesquisa.bvsalud.org
Background: COVID-19 has high mortality in hospitalized patients, and we need effective
treatments. Our objective was to assess corticosteroid pulses influence on 60-days mortality in …
treatments. Our objective was to assess corticosteroid pulses influence on 60-days mortality in …
Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients
MI Astigarraga Aguirre - 2021 - addi.ehu.es
Introduction: A growing evidence suggests that immune dysregulation and thrombotic
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
Clinical presentation of acute coronary syndrome in patients previously treated with nitrates
…, MP Fuset-Cabanes, E de Miguel Balsa… - Journal of …, 2013 - journals.lww.com
Aims Several reports have suggested that nitrates limit acute ischaemic damage by a mechanism
similar to preconditioning. This study aims to evaluate the effect of chronic oral nitrates …
similar to preconditioning. This study aims to evaluate the effect of chronic oral nitrates …
[PDF][PDF] ANÁLISIS DEL CORTE
CY RCP - semicyuc.org
… HOSPITAL UNIVERSITARIO MIGUEL SERVET (Zaragoza) … HOSPITAL GENERAL YAGÜE
(Burgos) Montón Rodríguez, Antonio José Montero Baladía, Miguel Gero Escapa, María …
(Burgos) Montón Rodríguez, Antonio José Montero Baladía, Miguel Gero Escapa, María …
Current evidence on the use of anakinra in COVID-19
Despite the progressing knowledge in COVID-19 management, remdesivir is the only agent
that got approval to inhibit viral replication. However, there are limited data about effective …
that got approval to inhibit viral replication. However, there are limited data about effective …